Loading organizations...
Loading organizations...
Integrated biopharmaceutical company focused on oncology products.
EOC Pharma Group has raised $103.0M across 2 funding rounds.
EOC Pharma Group has raised $103.0M in total across 2 funding rounds.
EOC Pharma Group has raised $103.0M in total across 2 funding rounds.
EOC Pharma Group's investors include Beijing Taikang Investment, Hongshan Capital Group (Sequoia Capital China), H&Q Asia Pacific.
EOC Pharma Group has raised $103.0M across 2 funding rounds. Most recently, it raised $71.0M Series C in December 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 2, 2019 | $71.0M Series C | ||
| Nov 7, 2017 | $32.0M Series B | Beijing Taikang Investment | Hongshan Capital Group (Sequoia Capital China), H&Q Asia Pacific |